Related Experiment Video
Updated: Oct 19, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase
K M Nicholson1, D M Quinn, G L Kellett
1Department of Biology, University of York, UK.
Abstract:
This study has compared the preferential killing of three multidrug-resistant (MDR) KB cell lines, KB-C1, KB-A1 and KB-V1 by two inhibitors of glucosylceramide synthase, 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) and 1-phenyl-2-hexadecanoylamino-3-pyrrolidino-1-propanol (PPPP), to the killing produced by these compounds in the drug-sensitive cell line, KB-3-1. Both of the inhibitors caused much greater induction of apoptosis in each of the three MDR cell lines than in the drug-sensitive cell line, as judged by morphological assay and confirmed by poly-(ADP-ribose)-polymerase cleavage. The highest level of apoptosis was produced following 24-h exposure to 5 microM PPPP. This treatment produced 75.8 (+/- 7.1)%, 73.6 (+/- 9.8)% and 75.3 (+/- 6.4)% apoptotic cells in the three MDR cell lines respectively, compared to 19.0 (+/- 9.8)% in the drug-sensitive cell line. A reduction in glucosylceramide level following inhibitor treatment occurred in KB-3-1 cells as well as in the MDR cell lines, suggesting that the increased apoptotic response in the MDR cells reflected a different downstream response to changes in the levels of this lipid in these cells compared to that in the drug-sensitive cells. These results suggest that the manipulation of glucosylceramide levels may be a fruitful way of causing the preferential killing of MDR cells in vitro and possibly in vivo.
Insights
Glucosylceramide synthase inhibitors like PPPP preferentially induce apoptosis in multidrug-resistant (MDR) cancer cells. This suggests targeting glucosylceramide levels could be a strategy for selective MDR cell killing.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Multidrug resistance (MDR) in cancer poses a significant therapeutic challenge.
- Targeting specific metabolic pathways offers potential strategies to overcome MDR.
Purpose of the Study:
- To compare the efficacy of glucosylceramide synthase inhibitors (PDMP and PPPP) in inducing apoptosis in MDR KB cell lines versus drug-sensitive cells.
- To investigate the role of glucosylceramide levels in the differential response of MDR cells to these inhibitors.
Main Methods:
- Treatment of three MDR KB cell lines (KB-C1, KB-A1, KB-V1) and one drug-sensitive KB-3-1 cell line with PDMP and PPPP.
- Assessment of apoptosis induction via morphological assays and poly-(ADP-ribose)-polymerase (PARP) cleavage.
- Measurement of glucosylceramide levels following inhibitor treatment.
Main Results:
- Both PDMP and PPPP induced significantly higher levels of apoptosis in MDR cell lines compared to the drug-sensitive cell line.
- Optimal apoptosis induction (75.8%) was observed in MDR cells after 24-hour exposure to 5 microM PPPP.
- Inhibitor treatment reduced glucosylceramide levels in both sensitive and resistant cells, indicating differential downstream signaling.
Conclusions:
- Glucosylceramide synthase inhibitors demonstrate preferential killing of MDR cancer cells.
- Modulating glucosylceramide levels presents a promising approach for selective MDR cell elimination in vitro and potentially in vivo.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Inhibitors of Bacterial Protein Synthesis
Gene Regulation in Microbial Communities: Quorum Sensing
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

